Interim report raises concerns about how Pharmac operates
Drug-buying agency puts too much emphasis on containing costs, report says.
Brent Edwards
Thu, 02 Dec 2021
Hot Topic
Hawke’s Bay
An interim report into drug-buying agency Pharmac has found its convoluted procurement process puts off pharmaceutical companies becoming involved.
The interim report, which does not make any recommendations, gives a taste of what the review panel has found so far, before it delivers its final
Want to read more? It's easy.
Choose your best value subscription option
Individual
Group membership
NBR Marketplace
Yearly Premium Online Subscription
NZ$499.00 / yearly
Monthly Premium Online Subscription
NZ$44.95 / monthly
Smartphone Only Subscription
NZ$24.95 / monthly
Premium Group Membership 10 Users
NZ$350+GST / monthly
$35 per user - Pay by monthly credit card debitPremium Group Membership 20 Users
NZ$600+GST / monthly
$30 per user - Pay by monthly credit card debitPremium Group Membership 50 Users
NZ$1250+GST / monthly
$25 per user - Pay by monthly credit card debitPremium Group Membership 100 Users
NZ$1875+GST / monthly
$18.75 per user - Pay by monthly credit card debitYearly Premium Online Subscription + NBR Marketplace
NZ$499.00 / yearly
Already have an account? Login
Brent Edwards
Thu, 02 Dec 2021
Contact the Writer: brent@nbr.co.nz
News tip? Question? Typo? Let us know: editor@nbr.co.nz
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.
Interim report raises concerns about how Pharmac operates
Politics,
89919